Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Decazes

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
PET Clinics|November 23, 2021
AI-Based Detection, Classification and Prediction/Prognosis in Medical Imaging:: Towards RadiophenomicsFereshteh Yousefirizi, Pierre Decazes, Amine Amyar, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|September 26, 2018
Semi-automatic lymphoma detection and segmentation using fully conditional random fieldsYuntao Yu, Pierre Decazes, Jérôme Lapuyade-Lahorgue, et al.
Computers in Biology and Medicine|October 28, 2022
Multi-scale feature similarity-based weakly supervised lymphoma segmentation in PET/CT imagesZhengshan Huang, Yu Guo, Ning Zhang, et al.
European Radiology|January 30, 2022
Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumoursCaroline Dominique, Françoise Callonnec, Anca Berghian, et al.
Annals of Nuclear Medicine|January 21, 2022
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumabFlorian Eude, Florian Guisier, Mathieu Salaün, et al.
Frontiers in Psychiatry|June 5, 2023
Anti-leucine-rich glioma-inactivated 1 encephalitis revealed by a manic episode: insights from frontal lobe dysfunction in neuropsychiatry through neuropsychology and metabolic imaging. A case reportFederica Porpiglia, Maxime Guillaume, Evangeline Bliaux, et al.
Cancer Medicine|October 20, 2022
The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapyRita Bentahila, Philippe Giraud, Pierre Decazes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2018
Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on <sup>18</sup>F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphomaPierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, et al.
Medical Physics|September 4, 2025
Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapyAya Terro, Solène Perret, Arthur Dumouchel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2018
Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphomaPierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
PET Clinics|November 23, 2021
AI-Based Detection, Classification and Prediction/Prognosis in Medical Imaging:: Towards RadiophenomicsFereshteh Yousefirizi, Pierre Decazes, Amine Amyar, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|September 26, 2018
Semi-automatic lymphoma detection and segmentation using fully conditional random fieldsYuntao Yu, Pierre Decazes, Jérôme Lapuyade-Lahorgue, et al.
Computers in Biology and Medicine|October 28, 2022
Multi-scale feature similarity-based weakly supervised lymphoma segmentation in PET/CT imagesZhengshan Huang, Yu Guo, Ning Zhang, et al.
European Radiology|January 30, 2022
Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumoursCaroline Dominique, Françoise Callonnec, Anca Berghian, et al.
Annals of Nuclear Medicine|January 21, 2022
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumabFlorian Eude, Florian Guisier, Mathieu Salaün, et al.
Frontiers in Psychiatry|June 5, 2023
Anti-leucine-rich glioma-inactivated 1 encephalitis revealed by a manic episode: insights from frontal lobe dysfunction in neuropsychiatry through neuropsychology and metabolic imaging. A case reportFederica Porpiglia, Maxime Guillaume, Evangeline Bliaux, et al.
Cancer Medicine|October 20, 2022
The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapyRita Bentahila, Philippe Giraud, Pierre Decazes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2018
Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on <sup>18</sup>F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphomaPierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, et al.
Medical Physics|September 4, 2025
Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapyAya Terro, Solène Perret, Arthur Dumouchel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2018
Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphomaPierre Decazes, Stéphanie Becker, Mathieu Nessim Toledano, et al.
Pageof 6